Trial
NCT00667628
Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Taiho Oncology, Inc.
Collaborators
Quintiles, Inc.
Condition
Advanced Hepatocellular Carcinoma
Intervention
TAC-101
Why stopped
Terminated due to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19